Telomeres and telomerase in Alzheimer's disease: Epiphenomena or a new focus for therapeutic strategy?

Alzheimer's and Dementia

Volumn 2, Issue 3, 2006, Pages 164-168

  Franco, Sonia ^a   Blasco, Maria A ^a   Siedlak, Sandra L ^b   Harris, Peggy L R ^b   Moreira, Paula I ^b,c   Perry, George ^b,d   Smith, Mark A ^b  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d University of San Antonio   (United States)

Author keywords

A PP transgenic mice; Alzheimer's disease; amyloid ; telomerase; telomerase length

Indexed keywords

ACETYLSALICYLIC ACID; AMYLOID PRECURSOR PROTEIN; DNA FRAGMENT; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERIC REPEAT BINDING FACTOR 2;

AGING; ALZHEIMER DISEASE; ARTICLE; CELL AGING; CELL POPULATION; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SPECIES DIFFERENCE; TELOMERE; TISSUE SPECIFICITY;

EID: 33744931650     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2006.03.001     Document Type: Article

References (39)

1. Perry G., Raina A.K., Cohen M.L., and Smith M.A. When hypotheses dominate. The Scientist 18 (2004) 6
2. Lee H.G., Casadesus G., Zhu X., Takeda A., Perry G., and Smith M.A. Challenging the amyloid cascade hypothesis. Senile plaques and amyloid-beta as protective adaptations to Alzheimer disease. Ann N Y Acad Sci 1019 (2004) 1-4
3. Nunomura A., Perry G., Pappolla M.A., Wade R., Hirai K., Chiba S., et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 19 (1999) 1959-1964
4. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21 (2001) 3017-3023
5. Perry G., Smith M.A., McCann C.E., Siedlak S.L., Jones P.K., and Friedland R.P. Cerebrovascular muscle atrophy is a feature of Alzheimer's disease. Brain Res 791 (1998) 63-66
6. Bowser R., and Smith M.A. Cell cycle proteins in Alzheimer's disease. Plenty of wheels but no cycle. J Alzheimers Dis 4 (2002) 249-254
7. Webber K.M., Casadesus G., Marlatt M.W., Perry G., Hamlin C.R., Atwood C.S., et al. Estrogen bows to a new master. The role of gonadotropins in Alzheimer pathogenesis. Ann N Y Acad Sci 1052 (2005) 201-209
8. Smith M.A., Sayre L.M., Monnier V.M., and Perry G. Radical AGEing in Alzheimer's disease. Trends Neurosci 18 (1995) 172-176
9. Raina A.K., Zhu X., Rottkamp C.A., Monteiro M., Takeda A., and Smith M.A. Cyclin' toward dementia. Cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. J Neurosci Res 61 (2000) 128-133
10. Flanary B.E., and Streit W.J. Telomeres shorten with age in rat cerebellum and cortex in vivo. J Anti Aging Med 6 (2003) 299-308
11. Satyanarayana A., Greenberg R.A., Schaetzlein S., Buer J., Masutomi K., Hahn W.C., et al. Mitogen stimulation cooperates with telomere shortening to activate DNA damage responses and senescence signaling. Mol Cell Biol 24 (2004) 5459-5474
12. Smogorzewska A., and de Lange T. Regulation of telomerase by telomeric proteins. Annu Rev Biochem 73 (2004) 177-208
13. Mattson M.P., Fu W., and Zhang P. Emerging roles for telomerase in regulating cell differentiation and survival. A neuroscientist's perspective. Mech Ageing Dev 122 (2001) 659-671
14. Harley C.B., Futcher A.B., and Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 345 (1990) 458-460
15. Proctor C.J., and Kirkwood T.B. Modelling telomere shortening and the role of oxidative stress. Mech Ageing Dev 123 (2002) 351-363
16. Kawanishi S., and Oikawa S. Mechanism of telomere shortening by oxidative stress. Ann N Y Acad Sci 1019 (2004) 278-284
17. Panossian L.A., Porter V.R., Valenzuela H.F., Zhu X., Reback E., Masterman D., et al. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging 24 (2003) 77-84
18. McShea A., Harris P.L., Webster K.R., Wahl A.F., and Smith M.A. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol 150 (1997) 1933-1939
19. Gonzalez-Suarez E., Geserick C., Flores J.M., and Blasco M.A. Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice. Oncogene 24 (2005) 2256-2270
20. Harley C.B. Telomerase therapeutics for degenerative diseases. Curr Mol Med 5 (2005) 205-211
21. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60 (2001) 759-767
22. Zarow C., Lyness S.A., Mortimer J.A., and Chui H.C. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60 (2003) 337-341
23. Bennett D.A., Schneider J.A., Wilson R.S., Bienias J.L., and Arnold S.E. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol 61 (2004) 378-384
24. Arendash G.W., Garcia M.F., Costa D.A., Cracchiolo J.R., Wefes I.M., and Potter H. Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition. Neuroreport 15 (2004) 1751-1754
25. Howlett D.R., Richardson J.C., Austin A., Parsons A.A., Bate S.T., Davies D.C., et al. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Brain Res 1017 (2004) 130-136
26. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 (1996) 99-102
27. Akbar A.N., Soares M.V., Plunkett F.J., and Salmon M. Differential regulation of CD8+ T cell senescence in mice and men. Mech Ageing Dev 121 (2000) 69-76
28. Sachsinger J., Gonzalez-Suarez E., Samper E., Heicappell R., Muller M., and Blasco M.A. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells. Cancer Res 61 (2001) 5580-5586
29. Zhang J., Kong Q., Zhang Z., Ge P., Ba D., and He W. Telomere dysfunction of lymphocytes in patients with Alzheimer disease. Cogn Behav Neurol 16 (2003) 170-176
30. Colurso G.J., Nilson J.E., and Vervoort L.G. Quantitative assessment of DNA fragmentation and beta-amyloid deposition in insular cortex and midfrontal gyrus from patients with Alzheimer's disease. Life Sci 73 (2003) 1795-1803
31. Ren J.G., Xia H.L., Just T., and Dai Y.R. Hydroxyl radical-induced apoptosis in human tumor cells is associated with telomere shortening but not telomerase inhibition and capsase activation. FEBS Lett 488 (2001) 123-132
32. Serra V., von Zglinicki T., Lorenz M., and Saretzki G. Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening. J Biol Chem 278 (2003) 6824-6830
33. Bode-Boger S.M., Martens-Lobenhoffer J., Tager M., Schroder H., and Scalera F. Aspirin reduces endothelial cell senescence. Biochem Biophys Res Commun 334 (2005) 1226-1232
34. Epel E.S., Blackburn E.H., Lin J., Dhabhar F.S., Adler N.E., Morrow J.D., et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A 101 (2004) 17312-17315
35. Bowles J.T. The evolution of aging. A new approach to an old problem of biology. Med Hypotheses 51 (1998) 179-221
36. Chung H.K., Cheong C., Song J., and Lee H.W. Extratelomeric functions of telomerase. Curr Mol Med 5 (2005) 233-241
37. Baek S., Bu Y., Kim H., and Kim H. Telomerase induction in astrocytes of Sprague-Dawley rat after ischemic brain injury. Neurosci Lett 363 (2004) 94-96
38. Kang H.J., Choi Y.S., Hong S.B., Kim K.W., Woo R.S., Won S.J., et al. Ectopic expression of the catalytic subunit of telomerase protects against brain injury resulting from ischemia and NMDA-induced neurotoxicity. J Neurosci 24 (2004) 1280-1287
39. Arkus N. A mathematical model of cellular apoptosis and senescence through the dynamics of telomere loss. J Theor Biol 235 (2005) 13-32